Newsfeeds - Spark Newswire

4 minute read

UAB And Mereo Announce Top-Line Results From COSTA Phase 1b/2 Trial Of Alvelestat (MPH966) In Hospitalized Patients With COVID-19 Respiratory Disease; Says ‘Alvelestat reported safe and well-tolerated in patients with COVID-19’

Today, 12:20 PM

Alvelestat reported safe and well-tolerated in patients with COVID-19 Alvelestat, on top of standard of care resulted in a more rapid time to improvement in WHO Disease Severity score of >=2

MREO

2 minute read

Events
News

Biomarker Data From Phase 1b/2 Investigator-sponsored Trial Of Mereo’s Alvelestat In Bronchiolitis Obliterans Syndrome At The ASH Annual Meeting

By Benzinga Newsdesk

Today, 12:20 PM

Mereo BioPharma Group plc (NASDAQ:MREO) ("Mereo" or the "Company"), a clinical stage biopharmaceutical company focused on oncology and rare diseases, today announced the presentation of data from the

MREO

1 minute read

Mereo BioPharma’s Etigilimab/Opdivo Combo Achieves One Complete Response In Cervical Cancer

By Vandana Singh

Today, 12:20 PM

Mereo BioPharma Group plc (NASDAQ: MREO)

BMY

2 minute read

Movers

12 Health Care Stocks Moving In Wednesday’s After-Market Session

By Benzinga Insights

Today, 12:20 PM

Gainers

AFIB

2 minute read

FDA
News

Mereo BioPharma And Ultragenyx Present Data From Phase 2b ASTEROID Study Of UX143 (setrusumab) In Osteogenesis Imperfecta (OI) At American Society For Bone And Mineral Research (ASBMR) 2021 Annual Meeting

By Benzinga Newsdesk

Today, 12:20 PM

Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), a biopharmaceutical company focused on the development and commercialization of novel products for serious rare and ultra-rare diseases, and Mereo BioPharma Group plc

MREO

1 minute read

12 Health Care Stocks Moving In Monday’s Pre-Market Session

By Benzinga Insights

Today, 12:20 PM

ADXN

1 minute read

Mereo’s Alvelestat Shows Encouraging Biomarker Data In Bronchiolitis Obliterans Syndrome

By Vandana Singh

Today, 12:20 PM

Mereo BioPharma Group plc (NASDAQ:MREO) has announced data from an interim analysis of an investigator-initiated study of alvelestat, in patients with…

MREO